Form 10-Q/A - Quarterly report [Sections 13 or 15(d)]: [Amend]

S&P TSX Capped Composite...

US Dollar vs CAD

Register for Free to get streaming real-time quotes, interactive charts, live options flow, and more.

Get Started

Form 10-Q/A - Quarterly report [Sections 13 or 15(d)]: [Amend]

Article too big to display. Click here to view on the SEC website

Repligen (NASDAQ:RGEN)
Historical Stock Chart
From Jan 2025 to Feb 2025

Click Here for more Repligen Charts.

Repligen (NASDAQ:RGEN)
Historical Stock Chart
From Feb 2024 to Feb 2025

Click Here for more Repligen Charts.

Repligen Corp News

Repligen Corporation to Present at 43rd Annual J.P. Morgan Healthcare Conference
Tuesday 7 January 2025 (4 weeks ago) • GlobeNewswire Inc.

Repligen Launches the CTech™ SoloVPE® PLUS System
Monday 6 January 2025 (4 weeks ago) • GlobeNewswire Inc.

BioLife Solutions Appoints Tony J. Hunt to its Board of Directors
Monday 16 December 2024 (2 months ago) • PR Newswire (US)

Repligen Announces Publication of the Company’s 2023 Corporate Sustainability Report
Thursday 12 December 2024 (2 months ago) • GlobeNewswire Inc.

Repligen Launches Novel AVIPure® dsRNA Resin in OPUS® Pre-packed Columns
Monday 9 December 2024 (2 months ago) • GlobeNewswire Inc.

Form 4 - Statement of changes in beneficial ownership of securities
Thursday 5 December 2024 (2 months ago) • Edgar (US Regulatory)

Form 4 - Statement of changes in beneficial ownership of securities
Friday 22 November 2024 (2 months ago) • Edgar (US Regulatory)

Form 144 - Report of proposed sale of securities
Thursday 21 November 2024 (2 months ago) • Edgar (US Regulatory)

Form 4 - Statement of changes in beneficial ownership of securities
Thursday 21 November 2024 (2 months ago) • Edgar (US Regulatory)

Form 4 - Statement of changes in beneficial ownership of securities
Thursday 21 November 2024 (2 months ago) • Edgar (US Regulatory)

Form 4 - Statement of changes in beneficial ownership of securities
Wednesday 20 November 2024 (2 months ago) • Edgar (US Regulatory)

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
Monday 18 November 2024 (2 months ago) • Edgar (US Regulatory)

More Repligen Corp News Articles

Northwest Biotherapeutics (QB)

Bioelectronics (PK)

Lehman Brothers Financial (CE)

Lightwave Logic

North Bay Resources (PK)

Fannie Mae (QB)

Elite Pharmaceuticals (QB)

Anavex Life Sciences

Delayed Upgrade Clock

Support: +44 (0) 203 8794 460 | support@advfn.com

By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions